Denali Therapeutics Inc. DNLI Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s total current liabilities?
- Denali Therapeutics Inc. (DNLI) reported total current liabilities of $110.16M in Q1 2026.
- How has Denali Therapeutics Inc.'s total current liabilities changed year-over-year?
- Denali Therapeutics Inc.'s total current liabilities increased by 19.9% year-over-year, from $91.88M to $110.16M.
- What is the long-term trend for Denali Therapeutics Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s total current liabilities has grown at a 6.5% compound annual growth rate (CAGR), from $71.7M to $98.35M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.